CARE Ratings
1,604.00
+18.30(+1.15%)
Market Cap₹4,811.19 Cr
PE Ratio30.68
Company Performance:
1D+1.15%
1M+7.29%
6M-9.19%
1Y+19.36%
5Y+210.19%
View Company Insightsright
More news about CARE Ratings
02Jul 25
SAT Overturns Sebi's Two-Year Ban on Former Care Ratings MD
The Securities Appellate Tribunal (SAT) has quashed a two-year ban imposed by Sebi on Rajesh Mokashi, former Managing Director of CARE Ratings. SAT criticized Sebi's action as a 'misadventure' and ordered the regulator to pay ₹5 lakh to Mokashi for appeal costs. The ban was related to alleged credit rating manipulation. This ruling could potentially impact CARE Ratings' reputation positively and highlights the importance of checks and balances in India's financial regulatory system.
13May 25
CARE Ratings Posts Impressive Q4 Results: PAT Surges 29%, Stock Soars 15%
CARE Ratings, an Indian credit rating agency, reported a 29% year-over-year increase in Q4 PAT to Rs 44.90 crore. Q4 revenue grew by 22% to Rs 91.20 crore. EBITDA increased by 31% with a 50.00% margin. The company announced a final dividend of Rs 11.00 per share. For the full fiscal year 2025, PAT rose 24% to Rs 147.90 crore with a 19% revenue growth. The stock price surged 15% in response to these results.
12May 25
CARE Ratings: Q4 Profit Surges 76%, ₹11 Dividend Declared
CARE Ratings announced strong Q4 FY25 results with a 76.40% increase in net profit to ₹43.40 crore. Revenue grew by 21.90% to ₹109.70 crore, while EBITDA rose 64.80% to ₹47.70 crore with a 43.20% margin. The company declared a final dividend of ₹11.00 per share and reported its highest-ever annual income from operations for FY25.
CARE Ratings
1,604.00
+18.30
(+1.15%)
1 Year Returns:+19.36%
Industry Peers
CRISIL
4,290.80
(+0.43%)
ICRA
6,299.50
(+1.64%)
CARE Ratings
1,604.00
(+1.15%)